 Tekla Life Sciences Investors NYSE:HQL President Daniel R. Omstead bought 8,300 shares of the firms stock in a transaction dated Tuesday, March 17th. The shares were acquired at an average price of 13.27 per share, with a total value of 110,141.00. Following the completion of the transaction, the president now owns 105,814 shares of the ... 